Teduglutide

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 336 publications

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

Journal: Bioconjugate chemistry

Published: April 10, 2026

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Journal: Current opinion in gastroenterology

Published: March 23, 2026

Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)

Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)

Journal: Zeitschrift fur Gastroenterologie

Published: February 11, 2026

Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence.

Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence.

Journal: Journal of clinical medicine

Published: February 04, 2026

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome.

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome.

Journal: Intestinal Failure (New York, N.Y.)

Published: January 19, 2026

Interpreting pooled GLP-2 analogue effects in chronic intestinal failure transparency, attrition, and real-world generalisability.

Interpreting pooled GLP-2 analogue effects in chronic intestinal failure transparency, attrition, and real-world generalisability.

Journal: Clinical nutrition ESPEN

Published: January 17, 2026

Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome.

Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome.

Journal: World journal of gastrointestinal pharmacology and therapeutics

Published: November 28, 2025

Loss of GLP-2R signaling in Glp2r-/- mice increases the long-term severity of graft versus host disease.

Loss of GLP-2R signaling in Glp2r-/- mice increases the long-term severity of graft versus host disease.

Journal: Molecular metabolism

Published: November 21, 2025

Teduglutide use in haemodialysis-dependent renal failure from secondary hyperoxaluria in short bowel syndrome and type 3 intestinal failure - A case report.

Teduglutide use in haemodialysis-dependent renal failure from secondary hyperoxaluria in short bowel syndrome and type 3 intestinal failure - A case report.

Journal: Intestinal Failure (New York, N.Y.)

Published: November 10, 2025

Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasms.

Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasms.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 15, 2025

Systemic Pharmacokinetic Principles of Therapeutic Peptides.

Systemic Pharmacokinetic Principles of Therapeutic Peptides.

Journal: Clinical pharmacokinetics

Published: August 21, 2025

Impact of teduglutide on pediatric short bowel syndrome: A systematic review and trial sequential meta-analysis.

Impact of teduglutide on pediatric short bowel syndrome: A systematic review and trial sequential meta-analysis.

Journal: World journal of gastrointestinal surgery

Published: August 04, 2025

Showing 1-12 of 336

Last Updated: 04/28/2026